Clinical proteomics: new trends for protein microarrays

Area of Science:

• Biotechnology
• Nanotechnology
• Proteomics

Background:

• Protein microarrays are advanced nanotechnology enabling simultaneous detection of numerous proteins.
• Current applications are primarily in basic science research.
• Clinical translation is hindered by a lack of consideration for real-world clinical settings and the limitations of cell line models in reflecting human disease complexity, particularly the absence of a tissue microenvironment.

Purpose of the Study:

• To review current protein microarray techniques for profiling tissues and specific cell populations in cancer patients.
• To explore the clinical applications of protein lysate microarrays.
• To discuss the utility of protein microarray technology in discovering disease markers for cancer diagnosis and personalized therapy.

Main Methods:

• Review of existing literature on protein microarray technologies.
• Focus on methods applicable to tissue and histopathology-defined cell population profiling.
• Analysis of clinical applications and potential for biomarker discovery.

Main Results:

• Protein microarrays show promise for analyzing proteomic changes in patient tissues.
• The technology facilitates the identification of disease markers relevant to cancer.
• Clinical applications are being developed for personalized cancer treatment strategies.

Conclusions:

• Protein microarrays are a valuable tool for advancing cancer diagnostics and personalized medicine.
• Further development is needed to bridge the gap between basic research and clinical application.
• The technology holds significant potential for discovering novel biomarkers for early cancer detection and tailored treatment approaches.